Problematic trial detection in ClinicalTrials.gov

C.H.J. Hartgerink, Stephen George

Research output: Contribution to journalArticleScientificpeer-review

4 Downloads (Pure)

Abstract

Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type.
Keywords: clinicaltrials.gov, problematic data, error, data fabrication
Original languageEnglish
Article numbere7462
JournalResearch Ideas and Outcomes
Volume1
DOIs
Publication statusPublished - 2015

Fingerprint

Databases

Cite this

Hartgerink, C.H.J. ; George, Stephen. / Problematic trial detection in ClinicalTrials.gov. In: Research Ideas and Outcomes. 2015 ; Vol. 1.
@article{dae57ec81d2649429e8e74152e186383,
title = "Problematic trial detection in ClinicalTrials.gov",
abstract = "Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type.Keywords: clinicaltrials.gov, problematic data, error, data fabrication",
author = "C.H.J. Hartgerink and Stephen George",
year = "2015",
doi = "10.3897/rio.1.e7462",
language = "English",
volume = "1",
journal = "Research Ideas and Outcomes",
issn = "2367-7163",

}

Problematic trial detection in ClinicalTrials.gov. / Hartgerink, C.H.J.; George, Stephen.

In: Research Ideas and Outcomes, Vol. 1, e7462, 2015.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Problematic trial detection in ClinicalTrials.gov

AU - Hartgerink, C.H.J.

AU - George, Stephen

PY - 2015

Y1 - 2015

N2 - Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type.Keywords: clinicaltrials.gov, problematic data, error, data fabrication

AB - Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type.Keywords: clinicaltrials.gov, problematic data, error, data fabrication

U2 - 10.3897/rio.1.e7462

DO - 10.3897/rio.1.e7462

M3 - Article

VL - 1

JO - Research Ideas and Outcomes

JF - Research Ideas and Outcomes

SN - 2367-7163

M1 - e7462

ER -